JPWO2020218382A1 - - Google Patents
Info
- Publication number
- JPWO2020218382A1 JPWO2020218382A1 JP2021516181A JP2021516181A JPWO2020218382A1 JP WO2020218382 A1 JPWO2020218382 A1 JP WO2020218382A1 JP 2021516181 A JP2021516181 A JP 2021516181A JP 2021516181 A JP2021516181 A JP 2021516181A JP WO2020218382 A1 JPWO2020218382 A1 JP WO2020218382A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Child & Adolescent Psychology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019086868 | 2019-04-26 | ||
| PCT/JP2020/017402 WO2020218382A1 (ja) | 2019-04-26 | 2020-04-22 | Ｇｌｐ－１分泌促進剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2020218382A1 true JPWO2020218382A1 (https=) | 2020-10-29 |
Family
ID=72941899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516181A Pending JPWO2020218382A1 (https=) | 2019-04-26 | 2020-04-22 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2020218382A1 (https=) |
| TW (1) | TW202106308A (https=) |
| WO (1) | WO2020218382A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001056959A1 (en) * | 2000-02-01 | 2001-08-09 | Stevia Aps | A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| WO2017018404A1 (ja) * | 2015-07-27 | 2017-02-02 | サントリーホールディングス株式会社 | 環状ジペプチド及び甘味料を含有する組成物 |
| WO2017159725A1 (ja) * | 2016-03-16 | 2017-09-21 | サントリーホールディングス株式会社 | Ｇｌｐ－１分泌促進用組成物及びその製造方法 |
| AU2017388706B2 (en) * | 2016-12-27 | 2022-04-21 | Suntory Holdings Limited | Novel steviol glycoside, method for producing same, and sweetener composition containing same |
| SG10202111903TA (en) * | 2017-03-31 | 2021-12-30 | Suntory Holdings Ltd | Novel steviol glycoside and production method therefor, and sweetener composition containing same |
-
2020
- 2020-04-22 JP JP2021516181A patent/JPWO2020218382A1/ja active Pending
- 2020-04-22 WO PCT/JP2020/017402 patent/WO2020218382A1/ja not_active Ceased
- 2020-04-24 TW TW109113760A patent/TW202106308A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020218382A1 (ja) | 2020-10-29 |
| TW202106308A (zh) | 2021-02-16 |